Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFM.L Regulatory News (AFM)

  • There is currently no data for AFM

Form 8.5 (EPT/NON-RI)

10 Jul 2024 11:43

RNS Number : 8916V
BNP Paribas London
10 July 2024
 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS

(OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

 

 (a) Name of exempt principal trader:

 

BNP Paribas Financial Markets

 (b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Alpha Financial Markets Consulting plc

 (c) Name of the party to the offer with which exempt principal trader is connected:

Bridgepoint Advisers Limited

 (d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

09/07/2024

 (e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No:

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

GB00BF16C058 (0.075p ordinary)

 

 

 

Interests

 

Short Positions

 

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

443,591

.36

-145,311

-.12

(2) Cash-settled derivatives:

 

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

TOTAL:

443,591

.36

-145,311

-.12

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)

Rights to subscribe for new securities (including directors'' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3.

DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

 

Class of

relevant

security

Purchase/

sales

Total number

of securities

Highest price

per unit

paid/received

Lowest price

per unit

paid/received

GB00BF16C058

Sale

-5,235

4.9550 GBP

4.9550 GBP

 

(b)

Cash-settled derivative transactions

 

Class of

relevant

security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a

long/short position

increasing/reducing a

long/short position

Number of

references

securities

Price per

unit

 

 

 

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

of

relevant

security

Product

description

e.g. call

option

Writing,

purchasing,

selling,

varying etc.

Number

of

securities

to which

option

relates

Exercise

price

per unit

Type

e.g.

American

European

etc.

Expiry

date

Option

money

paid/

received

per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

Class of

relevant

security

Product

description

e.g. call option

Exercising/

exercised

against

Number of

securities

Exercise price

per unit

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if

applicable)

 

 

 

 

 

 

 

 

 

4.

Other Information

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c)

Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

No

 

 

Date of Disclosure:

 

10/07/2024

Contact Name

 

Compliance Control Room

Telephone Number:

 

0207 595 9695

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOEAEXEFLALEFA
Date   Source Headline
10th Mar 20227:01 amRNSNotification of Major Holdings
10th Mar 20227:00 amRNSNotification of Major Holdings
3rd Mar 20227:00 amRNSDirector/PDMR Shareholding
2nd Mar 20227:00 amRNSCapital Markets Presentation
1st Feb 20227:00 amRNSTotal Voting Rights
18th Jan 20227:15 amRNSTotal Voting Rights
4th Jan 20229:00 amRNSTotal Voting Rights
14th Dec 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSInterim Results
22nd Nov 20213:19 pmRNSNotification of Major Holdings
6th Oct 20217:01 amRNSCapital Markets Presentation
6th Oct 20217:00 amRNSPre-close trading update
23rd Sep 20212:35 pmRNSResult of AGM
31st Aug 20217:00 amRNSTotal Voting Rights
26th Aug 20217:00 amRNSEmployee Benefit Trust Share Purchase
12th Aug 202112:00 pmRNSIssue of equity and total voting rights
3rd Aug 20217:00 amRNSPublication of Annual Report and Notice of AGM
2nd Aug 202111:56 amRNSTotal Voting Rights
7th Jul 20217:00 amRNSDirector/PDMR Shareholding
5th Jul 20217:00 amRNSExercise of Share Options and Total Voting Rights
24th Jun 20217:00 amRNSFull Year Results
26th May 202112:00 pmRNSDirector/PDMR Shareholding
21st May 20217:00 amRNSResults of Placing and Subscription
20th May 20214:42 pmRNSProposed Placing and Subscription
20th May 20214:39 pmRNSAcquisition of Lionpoint Holdings, Inc.
4th May 20218:47 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSPre-close trading update
16th Mar 202112:00 pmEQSEdison Investment Research Limited: Alphamin Resources (AFM): Initiation -⁠ Alpha tin actually
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSCapital Markets Presentation
18th Feb 20217:00 amRNSExercise of awards and total voting rights
26th Jan 20217:00 amRNSAppointment of Nominated Adviser
14th Jan 20217:00 amRNSGrant of incentive awards and total voting rights
7th Jan 202112:37 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSINTERIM RESULTS
5th Nov 20207:00 amRNSAppointment of Joint Broker
4th Nov 20209:00 amRNSNotice of interim results
29th Oct 20207:00 amRNSAlpha FMC launches dedicated ESG & RI practice
15th Oct 20207:00 amRNSStaff Incentive Awards and PDMR Shareholding
8th Oct 20207:00 amRNSPre-close trading update
23rd Sep 202012:28 pmRNSResult of AGM
23rd Sep 20208:36 amRNSHolding(s) in Company
19th Aug 20207:00 amRNSAnnual Report, Notice of AGM and Board change
23rd Jul 20207:16 amRNSStaff Incentive Awards and PDMR Shareholding
24th Jun 20207:00 amRNSFull Year Results
22nd Jun 20207:00 amRNSNon-Executive Director appointment
12th Jun 20209:49 amRNSNotice of Full Year Results
18th May 20203:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.